Today is November 21, 2009.
All times in Eastern Time.
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--CEO Thomas A. Moore of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, will present at the 8th Annual BIO... [ more ]
BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, ann... [ more ]
GLEN ALLEN, Va.--(BUSINESS WIRE)--Osteologix, Inc. (OTCBB: OLGX) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview and update at the 8th Annual B... [ more ]
BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, ann... [ more ]
SAN FRANCISCO--(BUSINESS WIRE)--Presidio Pharmaceuticals, Inc. announced today that Dr. Omar K. Haffar, President and Chief Executive Officer, will present an update on Presidio’s drug developme... [ more ]
SAN FRANCISCO--(BUSINESS WIRE)--The 2009 BIO Investor Forum takes place Oct. 28 - 29, 2009 at the Palace Hotel in San Francisco, CA. Business Wire is the official news wire for the 2009 BIO Investor F... [ more ]
WALTHAM, Mass.--(BUSINESS WIRE)--NeurAxon, Inc. is pleased to announce that Lawrence Bloch, M.D., J.D., the Company’s Chief Executive Officer, will be presenting at the following conferences: Th... [ more ]
NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 8th Annual BIO Investor Forum on Thursday,... [ more ]
SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard W. Pascoe, Somaxon’s president and chief executive officer, will be presenting at the 2009 BI... [ more ]
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO will present an overview of the company and its recently... [ more ]
HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced that President and Chief Executive Officer Igor Gonda, Ph.D., will present at the 2009 An... [ more ]
DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, P... [ more ]
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today annou... [ more ]
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Har... [ more ]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announc... [ more ]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-l... [ more ]
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced Plenary Session and Business Roundtable topics for the Eighth Annual BIO Investor Forum, taking place October... [ more ]
ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today ann... [ more ]
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced today the distinguished clinical investigators and industry experts participating on Therapeutic Workshops at the E... [ more ]
WASHINGTON--(BUSINESS WIRE)--Media registration is now available for the 8th Annual BIO Investor Forum - a national meeting with a special focus on investment strategies and competitive therapeutic an... [ more ]
WASHINGTON--(BUSINESS WIRE)--Registration is now available for the 8th Annual BIO Investor Forum - a national meeting focused on investment strategies and competitive therapeutic and drug development... [ more ]
|
|
